# PennyMac Financial Services, Inc.: financial statements, quarterly

PFSI · NYSE · CIK 1745916 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pfsi.md) · [Financials](/companies/pfsi/financials.md) · [Filings](/companies/pfsi/filings.md) · [Insiders](/companies/pfsi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pfsi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.9](/filings/0001558370-24-013853.md) | [5.4 d](/filings/0001104659-26-018142.md) | [3.6](/filings/0001558370-25-005840.md) | [15.7](/filings/0001558370-25-009736.md) | [3.4](/filings/0001104659-25-103162.md) | [4.1 d](/filings/0001104659-26-018142.md) | [4.9](/filings/0001104659-26-055690.md) | [4.5](/filings/0001104659-26-090486.md) | [4.6](/filings/0001104659-25-103162.md) | [6.1 d](/filings/0001104659-26-018142.md) | [6.1](/filings/0001104659-26-055690.md) | [19.5](/filings/0001104659-26-090486.md) |
| Interest expense | $m | [157](/filings/0001558370-23-017117.md) | [171 d](/filings/0001558370-24-001429.md) | [166](/filings/0001558370-24-006382.md) | [208](/filings/0001558370-24-010476.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [33.9](/filings/0001558370-24-013853.md) | [(17.4) d](/filings/0001104659-26-018142.md) | [4.6](/filings/0001558370-25-005840.md) | [35.6](/filings/0001558370-25-009736.md) | [24.6](/filings/0001104659-25-103162.md) | [24.9 d](/filings/0001104659-26-018142.md) | [27.9](/filings/0001104659-26-055690.md) | [(60.0)](/filings/0001104659-26-090486.md) | [54.9](/filings/0001104659-25-103162.md) | [27.6 d](/filings/0001104659-26-018142.md) | [22.4](/filings/0001104659-26-055690.md) | [9.8](/filings/0001104659-26-090486.md) |
| Net income | $m | [92.9](/filings/0001558370-24-013853.md) | [(36.8) d](/filings/0001104659-26-018142.md) | [39.3](/filings/0001558370-25-005840.md) | [98.3](/filings/0001558370-25-009736.md) | [69.4](/filings/0001104659-25-103162.md) | [104 d](/filings/0001104659-26-018142.md) | [76.3](/filings/0001104659-26-055690.md) | [136](/filings/0001104659-26-090486.md) | [182](/filings/0001104659-25-103162.md) | [107 d](/filings/0001104659-26-018142.md) | [82.3](/filings/0001104659-26-055690.md) | [21.7](/filings/0001104659-26-090486.md) |
| Diluted EPS | $ per share | [1.77](/filings/0001558370-24-013853.md) | not reported | [0.74](/filings/0001558370-25-005840.md) | [1.85](/filings/0001558370-25-009736.md) | [1.30](/filings/0001104659-25-103162.md) | not reported | [1.42](/filings/0001104659-26-055690.md) | [2.54](/filings/0001104659-26-090486.md) | [3.37](/filings/0001104659-25-103162.md) | not reported | [1.53](/filings/0001104659-26-055690.md) | [0.41](/filings/0001104659-26-090486.md) |
| Basic EPS | $ per share | [1.86](/filings/0001558370-24-013853.md) | not reported | [0.78](/filings/0001558370-25-005840.md) | [1.93](/filings/0001558370-25-009736.md) | [1.36](/filings/0001104659-25-103162.md) | not reported | [1.48](/filings/0001104659-26-055690.md) | [2.64](/filings/0001104659-26-090486.md) | [3.51](/filings/0001104659-25-103162.md) | not reported | [1.58](/filings/0001104659-26-055690.md) | [0.42](/filings/0001104659-26-090486.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.2](/filings/0001558370-23-017117.md) | [0.9](/filings/0001558370-25-001148.md) | [0.9](/filings/0001558370-24-006382.md) | [0.6](/filings/0001558370-24-010476.md) | [0.1](/filings/0001558370-24-013853.md) | [0.2](/filings/0001104659-26-018142.md) | [0.2](/filings/0001558370-25-005840.md) | [0.2](/filings/0001558370-25-009736.md) | [0.6](/filings/0001104659-25-103162.md) | [0.3](/filings/0001104659-26-090486.md) | [0.2](/filings/0001104659-26-055690.md) | [0.2](/filings/0001104659-26-090486.md) |
| Total assets | $bn | [18.9](/filings/0001558370-24-013853.md) | [18.8](/filings/0001104659-26-018142.md) | [19.8](/filings/0001558370-25-005840.md) | [21.6](/filings/0001558370-25-009736.md) | [22.9](/filings/0001104659-25-103162.md) | [26.1](/filings/0001104659-26-018142.md) | [23.9](/filings/0001104659-26-055690.md) | [24.2](/filings/0001104659-26-090486.md) | [25.4](/filings/0001104659-25-103162.md) | [29.4](/filings/0001104659-26-090486.md) | [31.9](/filings/0001104659-26-055690.md) | [29.9](/filings/0001104659-26-090486.md) |
| Total liabilities | $bn | [15.4](/filings/0001558370-23-017117.md) | [15.3](/filings/0001558370-25-001148.md) | [16.2](/filings/0001558370-24-006382.md) | [17.9](/filings/0001558370-24-010476.md) | [19.1](/filings/0001558370-24-013853.md) | [22.3](/filings/0001104659-26-018142.md) | [20.0](/filings/0001558370-25-005840.md) | [20.2](/filings/0001558370-25-009736.md) | [21.2](/filings/0001104659-25-103162.md) | [25.1](/filings/0001104659-26-090486.md) | [27.6](/filings/0001104659-26-055690.md) | [25.5](/filings/0001104659-26-090486.md) |
| Long-term debt | $bn | [4.5](/filings/0001558370-23-017117.md) | [4.4](/filings/0001558370-24-001429.md) | [4.5](/filings/0001558370-24-006382.md) | [4.9](/filings/0001558370-24-010476.md) | [4.9](/filings/0001558370-24-013853.md) | [5.3](/filings/0001558370-25-001148.md) | [5.8](/filings/0001558370-25-005840.md) | [5.6](/filings/0001558370-25-009736.md) | [6.2](/filings/0001104659-25-103162.md) | [6.2](/filings/0001104659-26-018142.md) | [6.2](/filings/0001104659-26-055690.md) | [6.3](/filings/0001104659-26-090486.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.6](/filings/0001558370-24-013853.md) | [3.5](/filings/0001104659-26-018142.md) | [3.6](/filings/0001558370-25-009736.md) | [3.7](/filings/0001104659-25-103162.md) | [3.7](/filings/0001104659-25-103162.md) | [3.8](/filings/0001104659-26-090486.md) | [3.9](/filings/0001104659-26-090486.md) | [4.0](/filings/0001104659-26-090486.md) | [4.2](/filings/0001104659-25-103162.md) | [4.3](/filings/0001104659-26-090486.md) | [4.3](/filings/0001104659-26-090486.md) | [4.3](/filings/0001104659-26-090486.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(976) d](/filings/0001558370-24-013853.md) | [430 d](/filings/0001104659-26-018142.md) | [(898)](/filings/0001558370-25-005840.md) | [(1,093) d](/filings/0001558370-25-009736.md) | [(394) d](/filings/0001104659-25-103162.md) | [(2,149) d](/filings/0001104659-26-018142.md) | [1,066](/filings/0001104659-26-055690.md) | [(131) d](/filings/0001104659-26-090486.md) | [(697) d](/filings/0001104659-25-103162.md) | [(1,889) d](/filings/0001104659-26-018142.md) | [(1,342)](/filings/0001104659-26-055690.md) | [2,143 d](/filings/0001104659-26-090486.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001558370-24-013853.md) | [0.5 d](/filings/0001104659-26-018142.md) | [0.9](/filings/0001558370-25-005840.md) | [0.4 d](/filings/0001558370-25-009736.md) | [0.1 d](/filings/0001104659-25-103162.md) | [0.2 d](/filings/0001104659-26-018142.md) | [0.4](/filings/0001104659-26-055690.md) | [1.3 d](/filings/0001104659-26-090486.md) | [2.1 d](/filings/0001104659-25-103162.md) | [8.2 d](/filings/0001104659-26-018142.md) | [2.3](/filings/0001104659-26-055690.md) | [3.4 d](/filings/0001104659-26-090486.md) |
| Dividends paid | $m | [10.2 d](/filings/0001558370-24-013853.md) | [10.2 d](/filings/0001104659-26-018142.md) | [10.4](/filings/0001558370-25-005840.md) | [10.4 d](/filings/0001558370-25-009736.md) | [15.7 d](/filings/0001104659-25-103162.md) | [15.7 d](/filings/0001104659-26-018142.md) | [15.0](/filings/0001104659-26-055690.md) | [15.8 d](/filings/0001104659-26-090486.md) | [15.8 d](/filings/0001104659-25-103162.md) | [15.9 d](/filings/0001104659-26-018142.md) | [15.6](/filings/0001104659-26-055690.md) | [15.9 d](/filings/0001104659-26-090486.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-24-013853.md) | [(0.1) d](/filings/0001104659-26-018142.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-26-018142.md) | [50.0](/filings/0001104659-26-055690.md) | [0.0 d](/filings/0001104659-26-090486.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.0](/filings/0001558370-23-017117.md) | [53.4](/filings/0001558370-24-006382.md) | [52.3](/filings/0001558370-24-010476.md) | [52.6](/filings/0001558370-24-013853.md) | [53.1](/filings/0001558370-25-005840.md) | [53.2](/filings/0001558370-25-009736.md) | [53.5](/filings/0001104659-25-103162.md) | [53.6](/filings/0001104659-26-055690.md) | [53.6](/filings/0001104659-26-090486.md) | [53.9](/filings/0001104659-25-103162.md) | [53.9](/filings/0001104659-26-055690.md) | [53.3](/filings/0001104659-26-090486.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,951,572 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001104659-26-090486.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.